Tag Archive for: market approval

Approval

Roche withdraws checkpoint blocker from the market

Roche AG’s US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer.

Read more